22-25761101-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032608.7(MYO18B):āc.9C>Gā(p.Ile3Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 1,612,852 control chromosomes in the GnomAD database, including 26,232 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.13 ( 1737 hom., cov: 33)
Exomes š: 0.18 ( 24495 hom. )
Consequence
MYO18B
NM_032608.7 missense
NM_032608.7 missense
Scores
2
5
10
Clinical Significance
Conservation
PhyloP100: 0.175
Genes affected
MYO18B (HGNC:18150): (myosin XVIIIB) The protein encoded by this gene may regulate muscle-specific genes when in the nucleus and may influence intracellular trafficking when in the cytoplasm. The encoded protein functions as a homodimer and may interact with F actin. Mutations in this gene are associated with lung cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0016304553).
BP6
Variant 22-25761101-C-G is Benign according to our data. Variant chr22-25761101-C-G is described in ClinVar as [Benign]. Clinvar id is 1321829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.192 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO18B | NM_032608.7 | c.9C>G | p.Ile3Met | missense_variant | 2/44 | ENST00000335473.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO18B | ENST00000335473.12 | c.9C>G | p.Ile3Met | missense_variant | 2/44 | 1 | NM_032608.7 | A2 | |
MYO18B | ENST00000407587.6 | c.9C>G | p.Ile3Met | missense_variant | 2/44 | 1 | P5 | ||
MYO18B | ENST00000536101.5 | c.9C>G | p.Ile3Met | missense_variant | 2/43 | 1 | A2 | ||
MYO18B | ENST00000539302.5 | c.9C>G | p.Ile3Met | missense_variant, NMD_transcript_variant | 1/42 | 1 |
Frequencies
GnomAD3 genomes AF: 0.132 AC: 20030AN: 152148Hom.: 1737 Cov.: 33
GnomAD3 genomes
AF:
AC:
20030
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.142 AC: 35447AN: 248832Hom.: 3147 AF XY: 0.147 AC XY: 19781AN XY: 134990
GnomAD3 exomes
AF:
AC:
35447
AN:
248832
Hom.:
AF XY:
AC XY:
19781
AN XY:
134990
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.176 AC: 256892AN: 1460586Hom.: 24495 Cov.: 32 AF XY: 0.175 AC XY: 127181AN XY: 726634
GnomAD4 exome
AF:
AC:
256892
AN:
1460586
Hom.:
Cov.:
32
AF XY:
AC XY:
127181
AN XY:
726634
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.132 AC: 20025AN: 152266Hom.: 1737 Cov.: 33 AF XY: 0.129 AC XY: 9588AN XY: 74444
GnomAD4 genome
AF:
AC:
20025
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
9588
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
713
ALSPAC
AF:
AC:
687
ESP6500AA
AF:
AC:
177
ESP6500EA
AF:
AC:
1622
ExAC
AF:
AC:
17150
Asia WGS
AF:
AC:
152
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
P;P;P
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Vest4
MPC
0.14
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at